28.11.2017 15:30:22: EXCITING NEW NATTOPHARMA PARTNERSHIPS & LAUNCH IN CHINA
New exclusive MenaQ7® product introduced to 150 invited distributors
OSLO, NORWAY AND EDISON, NJ - (NOVEMBER 28, 2017) -
Nattopharma was honored to participate in a launching conference commemorating
the first product introduced in China featuring MenaQ7® Vitamin K2 as MK-7.
FishBurg, a leading Chinese dietary supplement producer with a strong position
in the Calcium/Vitamin D3 (VD3) segment, signed a partnership and supply
agreement with NattoPharma, world leaders in Vitamin K2 as MK-7 research and
development, on November 28th in Guangzhou. During this event, FishBurg
officially launched its new Blue Hat-registered Calcium/VD3/MenaQ7 Vitamin K2
supplement for bone health to the Chinese market.
The event was attended by 150 distributors from across China, who will promote
the new FishBurg product via pharmacies and other Chinese dietary supplement
channels. During the event, FishBurg, NattoPharma, and the Norwegian council
made presentations that mark the start of this important partnership and entry
into the Chinese market. The event culminated with the signing of a strategic
partnership and supply agreement between FishBurg and NattoPharma, and a ribbon
-cutting ceremony.
"The product launch is a clear indication of the commitment from both parties,"
says Daniel Rosenbaum, NattoPharma CEO. “The event created excitement around
MenaQ7 Vitamin K2, which has amazing market potential in China.”
NattoPharma’s Chinese distributor partner Prochin hosted the event. According to
Jordan Yang, the commercial director of Prochin, distributors were excited to
learn about MenaQ7® arrival in China.
“FishBurg is quite confident that the newly launched Calcium/VD3/MenaQ7 Vitamin
K2 product will have a very impressive impact on the Chinese nutritional market,
bringing the benefits of bone and cardiovascular health to all customers,” said
by Youwen Chen, the CEO of FishBurg.
#
About NattoPharma and MenaQ7®
NattoPharma ASA, based in Norway, is the world’s leader in vitamin K2 research
and development. NattoPharma is the exclusive international supplier of MenaQ7®
Vitamin K2 as MK-7, the best documented, vitamin K2 as menaquinone-7 (MK-7) with
guaranteed actives and stability, clinical substantiation, and international
patents granted and pending, and now the new MenaQ7® Full Spectrum, which
delivers menaquinones 6, 7, 8, and 9. The company has a multi-year research and
development program to substantiate and discover the health benefits of vitamin
K2 for applications in the marketplace for functional food and dietary
supplements. With a global presence, the company established its North American
subsidiary, NattoPharma USA, Inc., in Edison, NJ, and NattoPharma R&D Ltd. in
Cyprus. For more information, visit www.nattopharma.com or www.menaq7.com.
About FishBurg
FishBurg is a company focused on the health industry. It intently serves people
who pursue high quality life experience with premium nutritional products and
professional health solutions. The development principle of FishBurg is “Sharing
health and love”. After intensive and comprehensive work on health and nutrition
industry, FishBurg currently is one of the most influential companies on the
market.
About Prochin
Prochin was one of the first foreign enterprises setup in the Shanghai Free
Trade Zone, focused on Food Ingredients. In fact, today, it is one of the
largest importers of dairy-based specialty ingredients in China! Over the years,
Prochin has built up an extensive network of foreign suppliers, Chinese
customers and logistics partners. It has redefined its strategy a few times over
the course of its 20 years of existence, but always focused on its two
mainstream business activities: 1) Functional Dairy Products & Ingredients, and
2) Nutritional Oils & Fats
